PiSA BioPharm Manufacturing Pilot Plant

PiSA BioPharm, a US based subsidiary of PiSA Farmacuetica, is exploring establishment of a major new manufacturing plant in the Capital Region of New York State. The proposed project involves PiSA BioPharm entering into a long-term lease for over 137,000 square feet of manufacturing space at the Rotterdam Corporate Park. The proposed new facility will be equipped with specialized manufacturing lines to accommodate state of the art equipment required to produce and package sterile injectables and specialized biomedical supplies. Outcomes include job creation and economic activity: it is anticipated that with NYS ESD support, PiSA BioPharm could bring over 100 jobs and more than $50 million in private investment to the Capital Region.Manufacturing has the highest multiplier effect of any economic sector. For every $1.00 spent in manufacturing, another $1.89 is added to the economy. This means that with an approximate $50 million dollar investment would yield an estimated $94.5 million to the economy. In addition, for every one worker in manufacturing, there are another four employees hired elsewhere. (Source: NAM calculations using IMPLAN)
Program Name:
Empire State Development Grant Funds
Agency ID:
Applicant Name:
PiSA BioPharm Inc
Capital District
CFA Number:
Round Number:
Round Key:
CFA Award Amount:
Grant Money Disbursed to Date:

Project Status:
Blue - Complete Green - On Schedule Yellow - Progressing Slowly Red - Concerns Pending Orange - Contract Not Executed Black - Cancelled/Declined